Meg Gallwitz is a 30-year industry veteran with global consulting experience leading quality and compliance initiatives, remediation projects, and serving as an expert in GMP compliance.

 

Meg has extensive expertise in areas of Quality Culture, data governance, and data integrity requirements, with broad-based, tactical experience applying current methodologies to enable organizational cultural change, and global/site-level data governance programs, as well as hands-on leadership for data integrity assessments, protocols, and investigations.

 

Meg’s approach leverages career learnings serving in  manufacturing, quality, and compliance executive roles with oversight of a broad range of pharmaceutical components and finished drug products including excipients, API’s, consumer products, oral solids, and parenteral finished drugs.

 

Meg was also a member of the 2022 PDA Data Integrity Workshop Planning Committee.